Innovid price target raised to $2.10 from $1.60 at Morgan Stanley

Morgan Stanley analyst Matthew Cost raised the firm’s price target on Innovid to $2.10 from $1.60 and keeps an Equal Weight rating on the shares. In a preview for the group, the firm says it will be watching ad tech results for commentary on 3 key themes: the health of the mobile app economy, cookie deprecation, and Connected TV, or CTV.